June 15, 2021
Business News

Forendo Pharma Appoints Dr Cristina Csimma as Chair of the Board of Directors


TURKU, Finland–()–Forendo Pharma, a clinical-stage drug development company focusing on novel treatments in women’s health, today announced that Dr Cristina Csimma has been appointed as Chair of the Board of Directors. Cristina brings with her deep expertise in the biopharmaceutical, venture capital, and academic sectors.

Commenting on the appointment, Risto Lammintausta, Chief Executive Officer of Forendo Pharma said: “Cristina’s extensive experience at the intersection of areas of global drug development and value creation in biotechnology companies makes her an invaluable addition to the Forendo team as we advance our lead compound towards clinical proof-of-concept in endometriosis patients. I am…



Click here to view the original article.

Related Posts

You might also like ...

Martin Foster Joins Cenlar as Senior Vice President of Servicing Operations
New Revenue Opportunities for the Channel with ViewSonic’s Partner Program in the Transition Back to the Office and Classroom
Insurity Summit 2021 to Announce the Launch of Insurity Analytics, Insurity’s Customer Innovation Center, and Multiple New Products, Including Digital Claims Payments